Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma
نویسندگان
چکیده
منابع مشابه
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...
متن کاملIntravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
We report a case of ocular ischemic syndrome accompanied by neovascular glaucoma that was successfully treated with Bevacizumab. A 70-year-old male patient diagnosed with neovascular glaucoma of the left eye 3-4 years prior complained of continuous left eye pain and declining visual acuity despite receiving the latest treatment methods. At the time of admission the patient had no light percepti...
متن کاملIntravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
PURPOSE To report the change in visual acuity and central retinal thickness by optical coherence tomography (OCT) after intravitreal injections of bevacizumab for the treatment of neovascular age-related macular degeneration (AMD). METHODS A retrospective case series in a university-based practice evaluated patients with subfoveal choroidal neovascularization (CNV) due to AMD. Patients receiv...
متن کامل[Intracameral bevacizumab (Avastin®) in the management of neovascular glaucoma surgery].
PURPOSE To describe a case series of neovascular glaucoma treated with intracameral bevacizumab prior to filtering surgery. DESIGN Descriptive, retrospective case series. METHODS Five eyes of 5 patients with neovascular glaucoma due to any cause candidates to filtering surgery who had previously received an injection of intracameral bevacizumab (1.25 mg/0.05 ml) as treatment for neovascular...
متن کاملintravitreal bevacizumab in neovascular glaucoma; a randomized clinical trial
purpose: to determine the effect of intravitreal bevacizumab (ivb) on neovascular glaucoma (nvg) in terms of intraocular pressure (iop), iris neovascularization (nvi) and best-corrected visual acuity (bcva). methods: in this randomized controlled trial, 26 eyes of 26 patients with nvg receiving conventional treatment were randomly allocated to three 2.5 mg ivb injections at 4-week intervals or ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical & Experimental Ophthalmology
سال: 2010
ISSN: 1442-6404,1442-9071
DOI: 10.1111/j.1442-9071.2010.02285.x